Healthcare2 months ago
Shilpa Medicare Limited (NSE: Shilpamed) Gets Final Approval for Oeristm
Shilpa Medicare Limited (NSE: SHILPAMED) secures final approval for OERISTM, the world's first extended-release ondansetron injection, marking a significant.